0001437749-21-009856.txt : 20210427 0001437749-21-009856.hdr.sgml : 20210427 20210427083047 ACCESSION NUMBER: 0001437749-21-009856 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20210427 DATE AS OF CHANGE: 20210427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Byrne Joseph A. CENTRAL INDEX KEY: 0001736911 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21856028 MAIL ADDRESS: STREET 1: 6 CAMERON SIDE ROAD EAST CITY: ESSEX STATE: A6 ZIP: N8M 2X5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5 1 rdgdoc.xml FORM 5 X0306 5 2018-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736911 Byrne Joseph A. 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Executive Officer* Common Stock 2018-01-14 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-02-14 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-03-15 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-04-17 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-05-14 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-06-15 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-07-16 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-08-16 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-09-16 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-10-17 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-11-20 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-12-14 4 J 0 L 2000 0 A 1425265 D Common Stock 2018-01-14 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-02-14 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-03-15 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-04-17 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-05-14 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-06-15 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-07-16 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-08-16 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-09-16 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-10-17 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-11-20 4 J 0 L 4000 0 A 1425265 I By Spouse Common Stock 2018-12-14 4 J 0 L 4000 0 A 1425265 I By Spouse 24,000 shares of the issuer held by the reporting person were issued as consideration for extending the maturity date of a promissory note dated January 24, 2018 and were acquired in increments of 2,000 shares on the following dates: 12/14/18; 11/20/18; 10/17/18; 9/16/18; 8/16/18; 7/16/18; 6/15/18; 5/14/18; 4/17/18; 1/24/18; 2/14/18; and 3/15/18. 48,000 shares of common stock of the issuer were issued to the Reporting Person's spouse as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 4,000 on the following dates: 1/14/18; 2/14/18; 3/15/18; 4/17/18; 5/14/18; 6/15/18; 7/16/18; 8/16/18; 9/16/18; 10/17/18; 11/20/18; and 12/14/18. 1,377,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person and 48,000 shares were held by the Reporting Person's spouse at 12/31/2018. *The reporting person served as the Chief Executive Officer and member of the Board of the Issuer from July 2017 until November 13, 2019, when the reporting person resigned from all positions with the Issuer. The reporting person was appointed as President and a member of the Board of the Issuer effective April 19, 2021. /s/ Joseph Byrne 2021-04-27